Position in NBIX
as of Mar 31, 2026
· filed Jun 15, 2026
Position Value
$24,503,640
+$15,483,252 QoQ
Shares Held
186,000
+192.5% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Carmignac Gestion holds $125,232,440 across 2 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
|
1,328,000 | $100,728,800 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
186,000 | $24,503,640 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $24,503,640 | 186,000 | Shares | Sole | 2026-06-15 | |
| 2025-12-31 | $9,020,388 | 63,600 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||